INS and obesity disorder: Circulating adiponectin levels are reduced in obesity [140,141,142], whereas the expressions of adiponectin receptors are increased, as evidenced by higher mRNA expressions of AdipoR1 in skeletal muscle in obese subjects [147] and AdipoR2 in insulin-resistant subjects [148].